Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Early accurate diagnosis crucial in multiple sclerosis.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Current options for the treatment of optic neuritis.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Mind-body medicine for multiple sclerosis: a systematic review.
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Idiopathic Acute Transverse Myelitis in Children: A Retrospective Series.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Monitoring neuromyelitis optica activity.
Diagnosis and classification of autoimmune optic neuropathy.
Comment on "matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis".
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
iPINBPA: AN INTEGRATIVE NETWORK-BASED FUNCTIONAL MODULE DISCOVERY TOOL FOR GENOME-WIDE ASSOCIATION STUDIES.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »